FindMyRecallSubscribe
Class III: unlikely to cause harmTerminated

Teva Pharmaceuticals Jolessa Recall

Jolessa (levonorgestrel/ethinyl estradiol) Tablets, 0

Teva Pharmaceuticals USA, Inc. · Sellersville, PA

Risk level
Class III
Reported by FDA
Apr 17, 2013
Recall ID
D-246-2013
Check your lot numberHow we source this data

Summary

Teva Pharmaceuticals recalled Jolessa starting Mar 12, 2013. The FDA classified it as Class III (unlikely to cause harm) and published enforcement report D-246-2013 on Apr 17, 2013. Reason: Failed Tablet/Capsule Specifications: This recall is being carried out due to an out of specification result for appearance. Status: Terminated.

Why it was recalled

Failed Tablet/Capsule Specifications: This recall is being carried out due to an out of specification result for appearance.

Product description

Jolessa (levonorgestrel/ethinyl estradiol) Tablets, 0.15 mg/0.03 mg, 91-count tablets per extended-cycle tablet dispenser packaged in 3 dispensers per carton, Rx only, Manufactured By: Barr Laboratories, Inc., Pomona, NY 10970; Manufactured For: Teva Pharmaceuticals USA, Sellersville, PA 18960, NDC 0555-9123-66.

Lot numbers, UPCs & expiration codes

Lot #: 33803603A, 33803604A, Exp 11/13; 33803996A, and 33803997A, Exp 03/14

Where it was sold

Nationwide

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-246-2013
Classification
Class III
Status
Terminated
Recall initiated
Mar 12, 2013
FDA report date
Apr 17, 2013
Quantity
71,893 dispensers
Recall type
Voluntary: Firm initiated
Recalling firm
Teva Pharmaceuticals USA, Inc.

Original FDA data

Every field from FDA enforcement report D-246-2013, exactly as published.

Show all FDA fields
City
Sellersville
State
PA
Status
Terminated
Country
United States
Event ID
64607
Address
650 Cathill Rd
Code information
Lot #: 33803603A, 33803604A, Exp 11/13; 33803996A, and 33803997A, Exp 03/14
Postal code
18960-1512
Report date
Apr 17, 2013
Product type
Drugs
Recall number
D-246-2013
Classification
Class III
Recalling firm
Teva Pharmaceuticals USA, Inc.
Product quantity
71,893 dispensers
Termination date
Jan 15, 2014
Reason for recall
Failed Tablet/Capsule Specifications: This recall is being carried out due to an out of specification result for appearance.
Voluntary / mandated
Voluntary: Firm initiated
Product description
Jolessa (levonorgestrel/ethinyl estradiol) Tablets, 0.15 mg/0.03 mg, 91-count tablets per extended-cycle tablet dispenser packaged in 3 dispensers per carton, Rx only, Manufactured By: Barr Laboratories, Inc., Pomona, NY 10970; Manufactured For: Teva Pharmaceuticals USA, Sellersville, PA 18960, NDC 0555-9123-66.
Distribution pattern
Nationwide
Recall initiation date
Mar 12, 2013
Initial firm notification
Letter
Center classification date
Apr 10, 2013

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-246-2013, published Apr 17, 2013. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls